Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

144.40USD
24 Jul 2014
Price Change (% chg)

$-0.31 (-0.21%)
Prev Close
$144.71
Open
--
Day's High
--
Day's Low
$144.40
Volume
1,358
Avg. Vol
9,459
52-wk High
$149.76
52-wk Low
$60.98

TARO.N

Chart for TARO.N

About

Taro Pharmaceutical Industries Ltd. is a science-based pharmaceutical company. The Company develops manufactures, and markets prescription and over-the-counter (OTC) pharmaceutical products, primarily in the United States, Canada and Israel. The Company also develops and manufactures active pharmaceutical ingredients (APIs),... (more)

Overall

Beta: 0.51
Market Cap (Mil.): $6,197.79
Shares Outstanding (Mil.): 42.83
Dividend: --
Yield (%): --

Financials

Search Stocks

Sun Pharma falls; unit Taro results fail to beat estimates

Reuters Market Eye - Shares of Sun Pharmaceutical Industries Ltd fall 0.9 percent after quarterly earnings at unit Taro Pharmaceutical Industries fail to beat some analyst estimates.

28 May 2014

MARKET EYE -India's Sun Pharma falls; unit Taro results fail to beat estimates

* Shares of India's Sun Pharmaceutical Industries Ltd fall 0.8 percent after quarterly earnings at unit Taro Pharmaceutical Industries fail to beat some analyst estimates. * Taro's revenue in January-March grew by 13 percent to $187 million, while profit jumped by 82 percent to $90 million. * Sun Pharma is scheduled to report its Jan-March results on Thursday. (abhishek.vishnoi@thomsonreuters.com / abhishek.vishnoi.thomsonreuters.com@reuters.net)

28 May 2014

Sun Pharma says seeks to enter Japan generics market

MUMBAI - Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of low-cost drugs, a senior executive said.

06 Mar 2014

Competitors

Earnings vs. Estimates

Search Stocks